Vital Therapies Files Registration Statement With SEC for Proposed Initial Public Offering——DFJ DragonFund China
 
ENGLISH 中文  
 
News
Home / News
Vital Therapies Files Registration Statement With SEC for Proposed Initial Public Offering
 
SAN DIEGO, CA (Marketwired - Oct 11, 2013) -  Vital Therapies, Inc., a biotherapeutic company developing a cell-based therapy targeting the treatment of acute liver failure, today announced that it has filed a registration statement with the U.S. Securities and Exchange Commission relating to a proposed initial public offering of shares of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined.
 
Credit Suisse Securities (USA) LLC and William Blair & Company, L.L.C. are acting as joint book-running managers for the offering. Cowen and Company, LLC and Canaccord Genuity Inc. are acting as co-managers for the offering.
 
A registration statement relating to these securities has been filed with the Securities and Exchange Commission, but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. 
 
The offering will be made only by means of a prospectus. Copies of the preliminary prospectus relating to the offering may be obtained, when available, from Credit Suisse Securities (USA) LLC, Attention: Prospectus Department, One Madison Avenue, New York, NY 10010, Telephone: (800) 221-1037, Email: newyork.prospectus@credit-suisse.com; or from William Blair & Company, L.L.C., Attention: Prospectus Department, 222 West Adams Street, Chicago, IL 60606, Telephone: (800) 621-0687.
 
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
 
 
CONTACT:
 
 Terry Winters 
 Co-Chairman & Chief Executive Officer 
 Duane Nash
 Chief Business Officer
 Vital Therapies, Inc.
 858-673-6840
 
Link:
http://vitaltherapies.mwnewsroom.com/press-releases/vital-therapies-files-registration-statement-with-sec-for-proposed-initial-publi-1058950
 
 
Copyright © 2015 DFJ DragonFund China.. All rights reserved Website:Wangnao
¼